IE45998B1 - Prolonged release pharmaceutical preparations - Google Patents

Prolonged release pharmaceutical preparations

Info

Publication number
IE45998B1
IE45998B1 IE2391/77A IE239177A IE45998B1 IE 45998 B1 IE45998 B1 IE 45998B1 IE 2391/77 A IE2391/77 A IE 2391/77A IE 239177 A IE239177 A IE 239177A IE 45998 B1 IE45998 B1 IE 45998B1
Authority
IE
Ireland
Prior art keywords
resin
drug
coating
particles
complex
Prior art date
Application number
IE2391/77A
Other languages
English (en)
Other versions
IE45998L (en
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of IE45998L publication Critical patent/IE45998L/xx
Publication of IE45998B1 publication Critical patent/IE45998B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IE2391/77A 1976-11-26 1977-11-25 Prolonged release pharmaceutical preparations IE45998B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74532576A 1976-11-26 1976-11-26
US80010577A 1977-05-24 1977-05-24

Publications (2)

Publication Number Publication Date
IE45998L IE45998L (en) 1978-05-26
IE45998B1 true IE45998B1 (en) 1983-01-26

Family

ID=27114439

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2391/77A IE45998B1 (en) 1976-11-26 1977-11-25 Prolonged release pharmaceutical preparations

Country Status (21)

Country Link
JP (1) JPS609697B2 (Sortimente)
AR (1) AR218047A1 (Sortimente)
AT (1) AT359197B (Sortimente)
AU (1) AU511080B2 (Sortimente)
BE (1) BE861141A (Sortimente)
CA (1) CA1086226A (Sortimente)
CH (1) CH639560A5 (Sortimente)
DE (1) DE2752728C2 (Sortimente)
DK (1) DK150534C (Sortimente)
FI (1) FI65910C (Sortimente)
FR (1) FR2373288A1 (Sortimente)
GB (1) GB1544761A (Sortimente)
GR (1) GR61724B (Sortimente)
IE (1) IE45998B1 (Sortimente)
IL (1) IL53462A (Sortimente)
LU (1) LU78584A1 (Sortimente)
NL (1) NL182283C (Sortimente)
NO (1) NO147626C (Sortimente)
NZ (1) NZ185772A (Sortimente)
PT (1) PT67323B (Sortimente)
SE (1) SE426781B (Sortimente)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2929456A1 (de) 1979-07-20 1981-02-05 Lentia Gmbh Zusammensetzung mit verlaengerter broncholytischer und tokolytischer wirksamkeit, ein verfahren zu deren herstellung und broncholytisch und tokolytisch wirkendes mittel
CA1236023A (en) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Controlled release pharmaceutical preparations
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5188825A (en) * 1989-12-28 1993-02-23 Iles Martin C Freeze-dried dosage forms and methods for preparing the same
US5876752A (en) * 1990-08-07 1999-03-02 Pfizer Inc. Use of interfacially-polymerized membranes in delivery devices
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
US20130230587A1 (en) * 2010-11-10 2013-09-05 Rubicon Research Private Limited Sustained release compositions
FR3059903B1 (fr) * 2016-12-08 2019-03-22 Salsarulo Pharma Medicament oral comprenant un laxatif osmotique incorpore dans une matrice a base de matieres grasses vegetales
EP3694555A4 (en) 2017-10-09 2021-07-07 Rhodes Pharmaceuticals L.P. RESINATE-BASED PHARMACEUTICAL COMPOSITIONS AND THEIR MANUFACTURING AND USE PROCESSES
WO2020234842A1 (en) * 2019-05-23 2020-11-26 G.D Societa' Per Azioni Filling unit to fill a container, in particular a cartridge, with a liquid product of the pharmaceutical industry

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE550150A (Sortimente) * 1955-08-08
GB843118A (en) * 1957-02-13 1960-08-04 Ici Ltd Pharmaceutical compositions containing piperidine derivatives
US3158538A (en) * 1961-02-23 1964-11-24 White Lab Inc Antidiarrheal compositions and method of using
GB982150A (en) * 1961-09-29 1965-02-03 Glaxo Group Ltd Therapeutic resin complexes
US3594470A (en) * 1968-02-19 1971-07-20 Abbott Lab Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin
GB1218102A (en) * 1968-03-15 1971-01-06 Philips Nv Improvements in medicaments comprising drug/ion-exchange resin compounds
CA935092A (en) * 1968-09-03 1973-10-09 S. Banker Gilbert Molecular drug entrapment process and compositions
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets

Also Published As

Publication number Publication date
SE7713370L (sv) 1978-05-27
NO147626B (no) 1983-02-07
PT67323A (en) 1977-12-01
DE2752728C2 (de) 1985-08-01
SE426781B (sv) 1983-02-14
BE861141A (fr) 1978-03-16
AR218047A1 (es) 1980-05-15
AT359197B (de) 1980-10-27
NL7712996A (nl) 1978-05-30
NO147626C (no) 1983-05-25
ATA848077A (de) 1980-03-15
DK150534C (da) 1987-10-12
PT67323B (en) 1979-04-24
JPS609697B2 (ja) 1985-03-12
GB1544761A (en) 1979-04-25
GR61724B (en) 1978-12-29
DE2752728A1 (de) 1978-06-01
AU3098677A (en) 1979-05-31
FI773568A7 (fi) 1978-05-27
CH639560A5 (en) 1983-11-30
LU78584A1 (Sortimente) 1978-04-20
FR2373288A1 (fr) 1978-07-07
JPS5369822A (en) 1978-06-21
NL182283C (nl) 1988-02-16
FI65910B (fi) 1984-04-30
AU511080B2 (en) 1980-07-24
FI65910C (fi) 1984-08-10
NZ185772A (en) 1978-12-18
CA1086226A (en) 1980-09-23
IE45998L (en) 1978-05-26
NL182283B (nl) 1987-09-16
DK150534B (da) 1987-03-23
FR2373288B1 (Sortimente) 1980-06-13
IL53462A0 (en) 1978-01-31
NO774051L (no) 1978-05-29
IL53462A (en) 1980-12-31
DK523277A (da) 1978-05-27

Similar Documents

Publication Publication Date Title
US4221778A (en) Prolonged release pharmaceutical preparations
Raghunathan et al. Sustained‐release drug delivery system I: Coated ion‐exchange resin system for phenylpropanolamine and other drugs
Guo et al. Ion-exchange resins as drug delivery carriers
JP2941314B2 (ja) 徐放性薬物‐樹脂複合体
EP0368682B1 (en) Pharmaceutical ion exchange resin composition
US4847077A (en) Controlled release pharmaceutical preparations
US6001392A (en) Antitussive drugs delivered by ion exchange resins
Borodkin Ion-exchange resin delivery systems
DK160601B (da) Farmaceutisk harpiksholdigt, sustained release praeparat med kontrolleret afgivelse af et farmaceutisk acceptabelt syreadditionssalt af dextromethorphan samt fremgangsmaade til fremstilling deraf
KR20080108520A (ko) 약물 - 이온교환 수지 복합체를 함유하는 변형 방출 제제
US4859461A (en) Coatable ion exchange resins
PT642785E (pt) Sistemas de hidrogel heterodisperso de libertacao sustida
CA2019108A1 (en) Sustained release pharmaceutical formulations
Elder Pharmaceutical applications of ion-exchange resins
Vijay et al. Ion exchange resins and their applications
Schacht Ionic polymers as drug carriers
NO852880L (no) Fremgangsmaate ved fremstilling av farmasoeytisk preparat med forsinket frigjoering
IE45998B1 (en) Prolonged release pharmaceutical preparations
EP2329813A1 (en) Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs
IE62100B1 (en) Coated ion exchange resins
PT99912A (pt) Processo para a preparacao de uma composicao farmaceutica oral compreendendo particulas de resina de permuta cationica que contem uma droga de poliamina farmacologicamente activa ligada a referida resina
CA1283497C (en) Polymer-treated ion exchange resins
EP2361611A2 (en) Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs
Jadhav et al. Ion exchange resins: a novel way to solve formulation problems
Verma et al. Rifabutin loaded floating gellan gum beads: In vitro and in vivo evaluation

Legal Events

Date Code Title Description
MK9A Patent expired